The Male Infertility Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Male Infertility Market: Drivers and Restraints
Some of the factors responsible for growth of male infertility market are changing lifestyle, increasing ages, excess consumption of alcohol and drugs, environmental factors and genetic abnormalities. Moreover, technological advancements are bridging the gap and the spending capacity of individuals has also increased. However, demand for male infertility treatment is increasing as there is increasing awareness among the people about their health problems and they are willing to overcoming the social taboo and accepting the fact of male infertility and turning towards the treatment options. But the high cost of treatment is a major hurdle to most of the people in need for this treatment. Also, the number of repeated treatment failures leads to emotional impact on the patient compelling the patient to opt out of the treatment which is also another limiting factors of male infertility treatment.
Male Infertility Market: Key Players
Some of the major market players of male infertility market include Access Pharmaceuticals, Inc., Andrology Solutions, ASKA Pharmaceutical Co. Ltd, Cordex Pharma, Inc., EMD Serona Inc., Halotech DNA SL, Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, SCSA Diagnostics, and Zydus Cadila Healthcare Limited. Rising incidences of male infertility, increasing healthcare expenditure, development of healthcare infrastructure and urge of having a baby leads to increase in adoption rate of the cutting age treatments leading to rise of the male infertility market.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14713
Male Infertility Market: Region-wise Outlook
Regionally, the market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominates the male infertility market due to factors like, increasing cases of male infertility due to life style factors such as obesity and diet, technological advancements which is fulfilling the need of treatment. Increasing cases of medical tourism and homosexuality in the U.S. is also boosting the male infertility market. Following North America is Europe owing to encouraging healthcare infrastructure and high healthcare expenditure in this region is the driving factors for male infertility market in this region. Asia Pacific is expected to be a significant market due to the rising infertility cases and awareness about infertility treatments and introduction of newer techniques in the treatment such as DNA fragmentation and computer assisted semen analysis. Government is also encouraging the adoption of the technological advancements but the private and public insurance plans rarely pay for infertility treatments which limits the lower income people to go for the treatment in this region.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/14713